GlassScriptPhysician profile
Frank P Cammisa
NPI 1275588246
$12,406.69
in general payments reported to CMS, 2019-2025
16 companies · $1,871 in 2025
The $1,871 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,673 · 2020: $158 · 2021: $513 · 2022: $2,362 · 2023: $475 · 2024: $4,355 · 2025: $1,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,782 · Food and Beverage: $2,919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,781.75 |
| Food and Beverage | $2,918.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $4,195.52 | 2019-2024 | Other - Miscellaneous |
| Orthofix Medical, INC. | $1,986.13 | 2019-2023 | Osteostrand Plus |
| Integrity Implants INC. | $1,956.77 | 2019-2022 | |
| Vb Spine LLC | $1,627.69 | 2025 | |
| Arteriocyte Medical Systems, INC. | $535.00 | 2022 | |
| Surgalign Spine Technologies, INC. | $407.49 | 2019 | |
| Kuros Biosciences USA, INC | $384.30 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $325.75 | 2020-2023 | Exparel, Iovera, Zilretta |
| Medical Device Business Services, INC. | $206.16 | 2024 | Conduit |
| Augmedics INC. | $195.43 | 2022-2023 | Xvision |
| 4web, INC. | $187.09 | 2024 | Spine Truss System |
| Centinel Spine, LLC | $156.50 | 2025 | Prodisc L |
| Nuvasive, INC. | $156.47 | 2019-2020 | |
| Stryker Corporation | $43.56 | 2025 | N/A |
| Mml US, INC. | $42.83 | 2025 | Reactiv8 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$45,123,644.60 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Cammisa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.